C12N 2795/00044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2795/00044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 6 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 9
- Assignees
- 3
- Inventors
- 10
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 3 | 3 |
| 2024 | 2 | 3 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Phagemid vector17 Jun 2025US 12,331,308 B2Imperial College Innovations Limited
- Production of lytic phages9 Apr 2024US 11,952,595 B2Eligo Bioscience
- Production bacterial cells and use thereof in production methods26 Mar 2024US 11,939,598 B2Eligo Bioscience
- Production of lytic phages29 Aug 2023US 11,739,304 B2Eligo Bioscience
- Production bacterial cells and use thereof in production methods11 Jul 2023US 11,697,802 B2Eligo Bioscience
- Production of lytic phages25 Jul 2024US 2024/0247238 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods6 Jun 2024US 2024/0182870 A1Eligo Bioscience
- Production of lytic phages11 Jan 2024US 2024/0010994 A1Eligo Bioscience
- Production bacterial cells and use thereof in production methods7 Sep 2023US 2023/0279364 A1Eligo Bioscience
- Phagemid Vector24 Aug 2023US 2023/0265452 A1Imperial College Innovations Limited
Most cited
By later US patents